| abstract |
An improved pharmaceutical composition comprising a ligand or agonist for the prostaglandin EP receptor and / or a cyclic AMP enhancer and a suitable organic solvent substantially free of methyl acetate is provided, the composition comprising: Provided for storage and / or use in endotoxin-free containers (eg, tubes or PE bags). The composition is suitable for in vitro, ex vivo, and in vivo use, and in particular for ex vivo therapeutic use (eg, in hematopoietic stem cell transplants). Also provided are methods for using the composition in ex vivo therapeutic applications, and methods for preparing the composition. A kit with instructions for use is also provided. |